SCHEMBL5205280

SCHEMBL5205280

CCc1ccc(Cc2cnc(N)nc2N2CCC(=O)CC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DHFR P00374 4/20 0.45
PKM P14618 1/20 0.41
PIK3CA P42336 1/20 0.40
MTOR P42345 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5203003 0.90 DHFR (0.40) DHFR
SCHEMBL5204379 0.88 DHFR (0.37) DHFR
SCHEMBL5204607 0.88 DHFR (0.40) DHFR
SCHEMBL5202924 0.87 DHFR (0.43) DHFRPKM
SCHEMBL5209661 0.86 DHFR (0.42) DHFRPIK3CAMTOR
SCHEMBL5206883 0.85 DHFR (0.43) DHFRPIK3CA
SCHEMBL7160558 0.80 PIK3CA (0.42) PIK3CAMTOR
SCHEMBL5202765 0.78 DHFR (0.38) DHFR
SCHEMBL5202458 0.77 DHFR (0.48) DHFR
SCHEMBL5202725 0.76 HSP90AA1 (0.38) DHFRPIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP claimed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US claimed
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP disclosed
US-6916820-B1 Neurotrophic substituted pyrimidines KRENITSKY PHARMACEUTICALS, INC. (US) 2005-07-12 US disclosed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed